During the past decade, UCSF Helen Diller Family Comprehensive Cancer Center conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 115 clinical trials were completed, i.e. on average, 102.7% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 36 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSF Helen Diller Family Comprehensive Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 92 trials, followed by "Children's Oncology Group" with 74 trials sponsored, "University of California, San Francisco" with 71 trials sponsored, "Radiation Therapy Oncology Group" with 57 trials sponsored and "SWOG Cancer Research Network" with 57 trials sponsored. Other sponsors include 289 different institutions and companies that sponsored additional 134 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Helen Diller Family Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 392 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 17 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator and "Eastern Cooperative Oncology Group" with 12 trials as a collaborator. Other collaborators include 173 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Helen Diller Family Comprehensive Cancer Center" are "Breast Cancer" (57 trials), "Prostate Cancer" (57 trials), "Leukemia" (53 trials), "Brain and Central Nervous System Tumors" (50 trials) and "Lymphoma" (44 trials). Many other conditions were trialed in "UCSF Helen Diller Family Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "UCSF Helen Diller Family Comprehensive Cancer Center" are "Drug" (477 trials), "Biological" (147 trials), "Radiation" (128 trials), "Procedure" (127 trials) and "Other" (65 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (76 trials), "filgrastim" (56 trials), "cyclophosphamide" (51 trials), "etoposide" (47 trials) and "doxorubicin hydrochloride" (42 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Helen Diller Family Comprehensive Cancer Center" are 494 trials for "All" genders, 70 trials for "Male" genders and 54 trials for "Female" genders.

Currently, there are NaN active trials in "UCSF Helen Diller Family Comprehensive Cancer Center". undefined are not yet recruiting, 29 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 455 completed trials in UCSF Helen Diller Family Comprehensive Cancer Center, undefined suspended trials, and 61 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Helen Diller Family Comprehensive Cancer Center, 177 "Phase 1" clinical trials were conducted, 283 "Phase 2" clinical trials and 140 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 31 trials that are defined as “Not Applicable".